Transcriptomics is the analysis of the RNA transcripts produced by the genotype at a given time that provides a link between the genome, the proteome, and the cellular phenotype. It is a global approach, which together with genomics, proteomics, and metabolomics has evolved in recent years.

The latest research study released by Market IntelliX evaluates market size and forecasts of RNA Analysis Transcriptomics in Global, including the following market information:

Global RNA Analysis Transcriptomics Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global RNA Analysis Transcriptomics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Microarrays Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of RNA Analysis Transcriptomics include Thermo Fisher Scientific, Bio-Rad Laboratories, Merck KGaA, Agilent Technologies, Illumina, QIAGEN N.V., F. Hoffmann-La Roche, Danaher Corporation and Fluidigm Corporation, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MI has surveyed the RNA Analysis Transcriptomics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Market Segmentations:

Global RNA Analysis Transcriptomics Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global RNA Analysis Transcriptomics Market Segment Percentages, by Type, 2021 (%)

Microarrays

Sequencing

Polymerase Chain Reaction (PCR)

RNA Interference

Global RNA Analysis Transcriptomics Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global RNA Analysis Transcriptomics Market Segment Percentages, by Application, 2021 (%)

Academic & Research Institutes

Pharmaceutical & Biotechnology Companies

Hospitals

Global RNA Analysis Transcriptomics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global RNA Analysis Transcriptomics Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies RNA Analysis Transcriptomics revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies RNA Analysis Transcriptomics revenues share in global market, 2021 (%)

The report presents profiles of competitors in the market Some of the prominent key players covered:

Thermo Fisher Scientific

Bio-Rad Laboratories

Merck KGaA

Agilent Technologies

Illumina

QIAGEN N.V.

F. Hoffmann-La Roche

Danaher Corporation

Fluidigm Corporation

Eurofins Scientific

Sequentia Biotech

Acobiom

GenXPro

CD Genomics

Promega Corporation

Lexogen

Cenix BioScience

Key Takeaways from this Report

Evaluate market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level – for product types, end use applications and by different industry verticals.

Understand the different dynamics influencing the market – key driving factors, challenges and hidden opportunities.

Get in-depth insights on your competitor performance – market shares, strategies, financial benchmarking, product benchmarking, SWOT and more.

Analyze the sales and distribution channels across key geographies to improve top-line revenues.

Understand the industry supply chain with a deep-dive on the value augmentation at each step, in order to optimize value and bring efficiencies in your processes.

Get a quick outlook on the market entropy – M&A’s, deals, partnerships, product launches of all key players for the past 4 years.

Evaluate the supply-demand gaps, import-export statistics and regulatory landscape for more than top 20 countries globally for the market.

1 Introduction to Research & Analysis Reports

1.1 RNA Analysis Transcriptomics Market Definition

1.2 Market Segments

1.2.1 Market by Type

1.2.2 Market by Application

1.3 Global RNA Analysis Transcriptomics Market Overview

1.4 Features & Benefits of This Report

1.5 Methodology & Sources of Information

1.5.1 Research Methodology

1.5.2 Research Process

1.5.3 Base Year

1.5.4 Report Assumptions & Caveats

2 Global RNA Analysis Transcriptomics Overall Market Size

2.1 Global RNA Analysis Transcriptomics Market Size: 2021 VS 2028

2.2 Global RNA Analysis Transcriptomics Market Size, Prospects & Forecasts: 2017-2028

2.3 Key Market Trends, Opportunity, Drivers and Restraints

2.3.1 Market Opportunities & Trends

2.3.2 Market Drivers

2.3.3 Market Restraints

3 Company Landscape

3.1 Top RNA Analysis Transcriptomics Players in Global Market

3.2 Top Global RNA Analysis Transcriptomics Companies Ranked by Revenue

3.3 Global RNA Analysis Transcriptomics Revenue by Companies

3.4 Top 3 and Top 5 RNA Analysis Transcriptomics Companies in Global Market, by Revenue in 2021

3.5 Global Companies RNA Analysis Transcriptomics Product Type

3.6 Tier 1, Tier 2 and Tier 3 RNA Analysis Transcriptomics Players in Global Market

3.6.1 List of Global Tier 1 RNA Analysis Transcriptomics Companies

3.6.2 List of Global Tier 2 and Tier 3 RNA Analysis Transcriptomics Companies

4 Market Sights by Product

4.1 Overview

4.1.1 by Type - Global RNA Analysis Transcriptomics Market Size Markets, 2021 & 2028

4.1.2 Microarrays

4.1.3 Sequencing

4.1.4 Polymerase Chain Reaction (PCR)

4.1.5 RNA Interference

4.2 By Type - Global RNA Analysis Transcriptomics Revenue & Forecasts

4.2.1 By Type - Global RNA Analysis Transcriptomics Revenue, 2017-2022

4.2.2 By Type - Global RNA Analysis Transcriptomics Revenue, 2023-2028

4.2.3 By Type - Global RNA Analysis Transcriptomics Revenue Market Share, 2017-2028

5 Sights by Application

5.1 Overview

5.1.1 By Application - Global RNA Analysis Transcriptomics Market Size, 2021 & 2028

5.1.2 Academic & Research Institutes

5.1.3 Pharmaceutical & Biotechnology Companies

5.1.4 Hospitals

5.2 By Application - Global RNA Analysis Transcriptomics Revenue & Forecasts

5.2.1 By Application - Global RNA Analysis Transcriptomics Revenue, 2017-2022

5.2.2 By Application - Global RNA Analysis Transcriptomics Revenue, 2023-2028

5.2.3 By Application - Global RNA Analysis Transcriptomics Revenue Market Share, 2017-2028

6 Sights by Region

6.1 By Region - Global RNA Analysis Transcriptomics Market Size, 2021 & 2028

6.2 By Region - Global RNA Analysis Transcriptomics Revenue & Forecasts

6.2.1 By Region - Global RNA Analysis Transcriptomics Revenue, 2017-2022

6.2.2 By Region - Global RNA Analysis Transcriptomics Revenue, 2023-2028

6.2.3 By Region - Global RNA Analysis Transcriptomics Revenue Market Share, 2017-2028

6.3 North America

6.3.1 By Country - North America RNA Analysis Transcriptomics Revenue, 2017-2028

6.3.2 US RNA Analysis Transcriptomics Market Size, 2017-2028

6.3.3 Canada RNA Analysis Transcriptomics Market Size, 2017-2028

6.3.4 Mexico RNA Analysis Transcriptomics Market Size, 2017-2028

6.4 Europe

6.4.1 By Country - Europe RNA Analysis Transcriptomics Revenue, 2017-2028

6.4.2 Germany RNA Analysis Transcriptomics Market Size, 2017-2028

6.4.3 France RNA Analysis Transcriptomics Market Size, 2017-2028

6.4.4 U.K. RNA Analysis Transcriptomics Market Size, 2017-2028

6.4.5 Italy RNA Analysis Transcriptomics Market Size, 2017-2028

6.4.6 Russia RNA Analysis Transcriptomics Market Size, 2017-2028

6.4.7 Nordic Countries RNA Analysis Transcriptomics Market Size, 2017-2028

6.4.8 Benelux RNA Analysis Transcriptomics Market Size, 2017-2028

6.5 Asia

6.5.1 By Region - Asia RNA Analysis Transcriptomics Revenue, 2017-2028

6.5.2 China RNA Analysis Transcriptomics Market Size, 2017-2028

6.5.3 Japan RNA Analysis Transcriptomics Market Size, 2017-2028

6.5.4 South Korea RNA Analysis Transcriptomics Market Size, 2017-2028

6.5.5 Southeast Asia RNA Analysis Transcriptomics Market Size, 2017-2028

6.5.6 India RNA Analysis Transcriptomics Market Size, 2017-2028

6.6 South America

6.6.1 By Country - South America RNA Analysis Transcriptomics Revenue, 2017-2028

6.6.2 Brazil RNA Analysis Transcriptomics Market Size, 2017-2028

6.6.3 Argentina RNA Analysis Transcriptomics Market Size, 2017-2028

6.7 Middle East & Africa

6.7.1 By Country - Middle East & Africa RNA Analysis Transcriptomics Revenue, 2017-2028

6.7.2 Turkey RNA Analysis Transcriptomics Market Size, 2017-2028

6.7.3 Israel RNA Analysis Transcriptomics Market Size, 2017-2028

6.7.4 Saudi Arabia RNA Analysis Transcriptomics Market Size, 2017-2028

6.7.5 UAE RNA Analysis Transcriptomics Market Size, 2017-2028

7 Players Profiles

7.1 Thermo Fisher Scientific

7.1.1 Thermo Fisher Scientific Corporate Summary

7.1.2 Thermo Fisher Scientific Business Overview

7.1.3 Thermo Fisher Scientific RNA Analysis Transcriptomics Major Product Offerings

7.1.4 Thermo Fisher Scientific RNA Analysis Transcriptomics Revenue in Global Market (2017-2022)

7.1.5 Thermo Fisher Scientific Key News

7.2 Bio-Rad Laboratories

7.2.1 Bio-Rad Laboratories Corporate Summary

7.2.2 Bio-Rad Laboratories Business Overview

7.2.3 Bio-Rad Laboratories RNA Analysis Transcriptomics Major Product Offerings

7.2.4 Bio-Rad Laboratories RNA Analysis Transcriptomics Revenue in Global Market (2017-2022)

7.2.5 Bio-Rad Laboratories Key News

7.3 Merck KGaA

7.3.1 Merck KGaA Corporate Summary

7.3.2 Merck KGaA Business Overview

7.3.3 Merck KGaA RNA Analysis Transcriptomics Major Product Offerings

7.3.4 Merck KGaA RNA Analysis Transcriptomics Revenue in Global Market (2017-2022)

7.3.5 Merck KGaA Key News

7.4 Agilent Technologies

7.4.1 Agilent Technologies Corporate Summary

7.4.2 Agilent Technologies Business Overview

7.4.3 Agilent Technologies RNA Analysis Transcriptomics Major Product Offerings

7.4.4 Agilent Technologies RNA Analysis Transcriptomics Revenue in Global Market (2017-2022)

7.4.5 Agilent Technologies Key News

7.5 Illumina

7.5.1 Illumina Corporate Summary

7.5.2 Illumina Business Overview

7.5.3 Illumina RNA Analysis Transcriptomics Major Product Offerings

7.5.4 Illumina RNA Analysis Transcriptomics Revenue in Global Market (2017-2022)

7.5.5 Illumina Key News

7.6 QIAGEN N.V.

7.6.1 QIAGEN N.V. Corporate Summary

7.6.2 QIAGEN N.V. Business Overview

7.6.3 QIAGEN N.V. RNA Analysis Transcriptomics Major Product Offerings

7.6.4 QIAGEN N.V. RNA Analysis Transcriptomics Revenue in Global Market (2017-2022)

7.6.5 QIAGEN N.V. Key News

7.7 F. Hoffmann-La Roche

7.7.1 F. Hoffmann-La Roche Corporate Summary

7.7.2 F. Hoffmann-La Roche Business Overview

7.7.3 F. Hoffmann-La Roche RNA Analysis Transcriptomics Major Product Offerings

7.7.4 F. Hoffmann-La Roche RNA Analysis Transcriptomics Revenue in Global Market (2017-2022)

7.7.5 F. Hoffmann-La Roche Key News

7.8 Danaher Corporation

7.8.1 Danaher Corporation Corporate Summary

7.8.2 Danaher Corporation Business Overview

7.8.3 Danaher Corporation RNA Analysis Transcriptomics Major Product Offerings

7.8.4 Danaher Corporation RNA Analysis Transcriptomics Revenue in Global Market (2017-2022)

7.8.5 Danaher Corporation Key News

7.9 Fluidigm Corporation

7.9.1 Fluidigm Corporation Corporate Summary

7.9.2 Fluidigm Corporation Business Overview

7.9.3 Fluidigm Corporation RNA Analysis Transcriptomics Major Product Offerings

7.9.4 Fluidigm Corporation RNA Analysis Transcriptomics Revenue in Global Market (2017-2022)

7.9.5 Fluidigm Corporation Key News

7.10 Eurofins Scientific

7.10.1 Eurofins Scientific Corporate Summary

7.10.2 Eurofins Scientific Business Overview

7.10.3 Eurofins Scientific RNA Analysis Transcriptomics Major Product Offerings

7.10.4 Eurofins Scientific RNA Analysis Transcriptomics Revenue in Global Market (2017-2022)

7.10.5 Eurofins Scientific Key News

7.11 Sequentia Biotech

7.11.1 Sequentia Biotech Corporate Summary

7.11.2 Sequentia Biotech Business Overview

7.11.3 Sequentia Biotech RNA Analysis Transcriptomics Major Product Offerings

7.11.4 Sequentia Biotech RNA Analysis Transcriptomics Revenue in Global Market (2017-2022)

7.11.5 Sequentia Biotech Key News

7.12 Acobiom

7.12.1 Acobiom Corporate Summary

7.12.2 Acobiom Business Overview

7.12.3 Acobiom RNA Analysis Transcriptomics Major Product Offerings

7.12.4 Acobiom RNA Analysis Transcriptomics Revenue in Global Market (2017-2022)

7.12.5 Acobiom Key News

7.13 GenXPro

7.13.1 GenXPro Corporate Summary

7.13.2 GenXPro Business Overview

7.13.3 GenXPro RNA Analysis Transcriptomics Major Product Offerings

7.13.4 GenXPro RNA Analysis Transcriptomics Revenue in Global Market (2017-2022)

7.13.5 GenXPro Key News

7.14 CD Genomics

7.14.1 CD Genomics Corporate Summary

7.14.2 CD Genomics Business Overview

7.14.3 CD Genomics RNA Analysis Transcriptomics Major Product Offerings

7.14.4 CD Genomics RNA Analysis Transcriptomics Revenue in Global Market (2017-2022)

7.14.5 CD Genomics Key News

7.15 Promega Corporation

7.15.1 Promega Corporation Corporate Summary

7.15.2 Promega Corporation Business Overview

7.15.3 Promega Corporation RNA Analysis Transcriptomics Major Product Offerings

7.15.4 Promega Corporation RNA Analysis Transcriptomics Revenue in Global Market (2017-2022)

7.15.5 Promega Corporation Key News

7.16 Lexogen

7.16.1 Lexogen Corporate Summary

7.16.2 Lexogen Business Overview

7.16.3 Lexogen RNA Analysis Transcriptomics Major Product Offerings

7.16.4 Lexogen RNA Analysis Transcriptomics Revenue in Global Market (2017-2022)

7.16.5 Lexogen Key News

7.17 Cenix BioScience

7.17.1 Cenix BioScience Corporate Summary

7.17.2 Cenix BioScience Business Overview

7.17.3 Cenix BioScience RNA Analysis Transcriptomics Major Product Offerings

7.17.4 Cenix BioScience RNA Analysis Transcriptomics Revenue in Global Market (2017-2022)

7.17.5 Cenix BioScience Key News

8 Conclusion

9 Appendix

9.1 Note

9.2 Examples of Clients

9.3 Disclaimer

List of Tables

Table 1. RNA Analysis Transcriptomics Market Opportunities & Trends in Global Market

Table 2. RNA Analysis Transcriptomics Market Drivers in Global Market

Table 3. RNA Analysis Transcriptomics Market Restraints in Global Market

Table 4. Key Players of RNA Analysis Transcriptomics in Global Market

Table 5. Top RNA Analysis Transcriptomics Players in Global Market, Ranking by Revenue (2021)

Table 6. Global RNA Analysis Transcriptomics Revenue by Companies, (US$, Mn), 2017-2022

Table 7. Global RNA Analysis Transcriptomics Revenue Share by Companies, 2017-2022

Table 8. Global Companies RNA Analysis Transcriptomics Product Type

Table 9. List of Global Tier 1 RNA Analysis Transcriptomics Companies, Revenue (US$, Mn) in 2021 and Market Share

Table 10. List of Global Tier 2 and Tier 3 RNA Analysis Transcriptomics Companies, Revenue (US$, Mn) in 2021 and Market Share

Table 11. By Type – Global RNA Analysis Transcriptomics Revenue, (US$, Mn), 2021 & 2028

Table 12. By Type - RNA Analysis Transcriptomics Revenue in Global (US$, Mn), 2017-2022

Table 13. By Type - RNA Analysis Transcriptomics Revenue in Global (US$, Mn), 2023-2028

Table 14. By Application – Global RNA Analysis Transcriptomics Revenue, (US$, Mn), 2021 & 2028

Table 15. By Application - RNA Analysis Transcriptomics Revenue in Global (US$, Mn), 2017-2022

Table 16. By Application - RNA Analysis Transcriptomics Revenue in Global (US$, Mn), 2023-2028

Table 17. By Region – Global RNA Analysis Transcriptomics Revenue, (US$, Mn), 2021 & 2028

Table 18. By Region - Global RNA Analysis Transcriptomics Revenue (US$, Mn), 2017-2022

Table 19. By Region - Global RNA Analysis Transcriptomics Revenue (US$, Mn), 2023-2028

Table 20. By Country - North America RNA Analysis Transcriptomics Revenue, (US$, Mn), 2017-2022

Table 21. By Country - North America RNA Analysis Transcriptomics Revenue, (US$, Mn), 2023-2028

Table 22. By Country - Europe RNA Analysis Transcriptomics Revenue, (US$, Mn), 2017-2022

Table 23. By Country - Europe RNA Analysis Transcriptomics Revenue, (US$, Mn), 2023-2028

Table 24. By Region - Asia RNA Analysis Transcriptomics Revenue, (US$, Mn), 2017-2022

Table 25. By Region - Asia RNA Analysis Transcriptomics Revenue, (US$, Mn), 2023-2028

Table 26. By Country - South America RNA Analysis Transcriptomics Revenue, (US$, Mn), 2017-2022

Table 27. By Country - South America RNA Analysis Transcriptomics Revenue, (US$, Mn), 2023-2028

Table 28. By Country - Middle East & Africa RNA Analysis Transcriptomics Revenue, (US$, Mn), 2017-2022

Table 29. By Country - Middle East & Africa RNA Analysis Transcriptomics Revenue, (US$, Mn), 2023-2028

Table 30. Thermo Fisher Scientific Corporate Summary

Table 31. Thermo Fisher Scientific RNA Analysis Transcriptomics Product Offerings

Table 32. Thermo Fisher Scientific RNA Analysis Transcriptomics Revenue (US$, Mn), (2017-2022)

Table 33. Bio-Rad Laboratories Corporate Summary

Table 34. Bio-Rad Laboratories RNA Analysis Transcriptomics Product Offerings

Table 35. Bio-Rad Laboratories RNA Analysis Transcriptomics Revenue (US$, Mn), (2017-2022)

Table 36. Merck KGaA Corporate Summary

Table 37. Merck KGaA RNA Analysis Transcriptomics Product Offerings

Table 38. Merck KGaA RNA Analysis Transcriptomics Revenue (US$, Mn), (2017-2022)

Table 39. Agilent Technologies Corporate Summary

Table 40. Agilent Technologies RNA Analysis Transcriptomics Product Offerings

Table 41. Agilent Technologies RNA Analysis Transcriptomics Revenue (US$, Mn), (2017-2022)

Table 42. Illumina Corporate Summary

Table 43. Illumina RNA Analysis Transcriptomics Product Offerings

Table 44. Illumina RNA Analysis Transcriptomics Revenue (US$, Mn), (2017-2022)

Table 45. QIAGEN N.V. Corporate Summary

Table 46. QIAGEN N.V. RNA Analysis Transcriptomics Product Offerings

Table 47. QIAGEN N.V. RNA Analysis Transcriptomics Revenue (US$, Mn), (2017-2022)

Table 48. F. Hoffmann-La Roche Corporate Summary

Table 49. F. Hoffmann-La Roche RNA Analysis Transcriptomics Product Offerings

Table 50. F. Hoffmann-La Roche RNA Analysis Transcriptomics Revenue (US$, Mn), (2017-2022)

Table 51. Danaher Corporation Corporate Summary

Table 52. Danaher Corporation RNA Analysis Transcriptomics Product Offerings

Table 53. Danaher Corporation RNA Analysis Transcriptomics Revenue (US$, Mn), (2017-2022)

Table 54. Fluidigm Corporation Corporate Summary

Table 55. Fluidigm Corporation RNA Analysis Transcriptomics Product Offerings

Table 56. Fluidigm Corporation RNA Analysis Transcriptomics Revenue (US$, Mn), (2017-2022)

Table 57. Eurofins Scientific Corporate Summary

Table 58. Eurofins Scientific RNA Analysis Transcriptomics Product Offerings

Table 59. Eurofins Scientific RNA Analysis Transcriptomics Revenue (US$, Mn), (2017-2022)

Table 60. Sequentia Biotech Corporate Summary

Table 61. Sequentia Biotech RNA Analysis Transcriptomics Product Offerings

Table 62. Sequentia Biotech RNA Analysis Transcriptomics Revenue (US$, Mn), (2017-2022)

Table 63. Acobiom Corporate Summary

Table 64. Acobiom RNA Analysis Transcriptomics Product Offerings

Table 65. Acobiom RNA Analysis Transcriptomics Revenue (US$, Mn), (2017-2022)

Table 66. GenXPro Corporate Summary

Table 67. GenXPro RNA Analysis Transcriptomics Product Offerings

Table 68. GenXPro RNA Analysis Transcriptomics Revenue (US$, Mn), (2017-2022)

Table 69. CD Genomics Corporate Summary

Table 70. CD Genomics RNA Analysis Transcriptomics Product Offerings

Table 71. CD Genomics RNA Analysis Transcriptomics Revenue (US$, Mn), (2017-2022)

Table 72. Promega Corporation Corporate Summary

Table 73. Promega Corporation RNA Analysis Transcriptomics Product Offerings

Table 74. Promega Corporation RNA Analysis Transcriptomics Revenue (US$, Mn), (2017-2022)

Table 75. Lexogen Corporate Summary

Table 76. Lexogen RNA Analysis Transcriptomics Product Offerings

Table 77. Lexogen RNA Analysis Transcriptomics Revenue (US$, Mn), (2017-2022)

Table 78. Cenix BioScience Corporate Summary

Table 79. Cenix BioScience RNA Analysis Transcriptomics Product Offerings

Table 80. Cenix BioScience RNA Analysis Transcriptomics Revenue (US$, Mn), (2017-2022)

List of Figures

Figure 1. RNA Analysis Transcriptomics Segment by Type in 2021

Figure 2. RNA Analysis Transcriptomics Segment by Application in 2021

Figure 3. Global RNA Analysis Transcriptomics Market Overview: 2021

Figure 4. Key Caveats

Figure 5. Global RNA Analysis Transcriptomics Market Size: 2021 VS 2028 (US$, Mn)

Figure 6. Global RNA Analysis Transcriptomics Revenue, 2017-2028 (US$, Mn)

Figure 7. The Top 3 and 5 Players Market Share by RNA Analysis Transcriptomics Revenue in 2021

Figure 8. By Type - Global RNA Analysis Transcriptomics Revenue Market Share, 2017-2028

Figure 9. By Application - Global RNA Analysis Transcriptomics Revenue Market Share, 2017-2028

Figure 10. By Region - Global RNA Analysis Transcriptomics Revenue Market Share, 2017-2028

Figure 11. By Country - North America RNA Analysis Transcriptomics Revenue Market Share, 2017-2028

Figure 12. US RNA Analysis Transcriptomics Revenue, (US$, Mn), 2017-2028

Figure 13. Canada RNA Analysis Transcriptomics Revenue, (US$, Mn), 2017-2028

Figure 14. Mexico RNA Analysis Transcriptomics Revenue, (US$, Mn), 2017-2028

Figure 15. By Country - Europe RNA Analysis Transcriptomics Revenue Market Share, 2017-2028

Figure 16. Germany RNA Analysis Transcriptomics Revenue, (US$, Mn), 2017-2028

Figure 17. France RNA Analysis Transcriptomics Revenue, (US$, Mn), 2017-2028

Figure 18. U.K. RNA Analysis Transcriptomics Revenue, (US$, Mn), 2017-2028

Figure 19. Italy RNA Analysis Transcriptomics Revenue, (US$, Mn), 2017-2028

Figure 20. Russia RNA Analysis Transcriptomics Revenue, (US$, Mn), 2017-2028

Figure 21. Nordic Countries RNA Analysis Transcriptomics Revenue, (US$, Mn), 2017-2028

Figure 22. Benelux RNA Analysis Transcriptomics Revenue, (US$, Mn), 2017-2028

Figure 23. By Region - Asia RNA Analysis Transcriptomics Revenue Market Share, 2017-2028

Figure 24. China RNA Analysis Transcriptomics Revenue, (US$, Mn), 2017-2028

Figure 25. Japan RNA Analysis Transcriptomics Revenue, (US$, Mn), 2017-2028

Figure 26. South Korea RNA Analysis Transcriptomics Revenue, (US$, Mn), 2017-2028

Figure 27. Southeast Asia RNA Analysis Transcriptomics Revenue, (US$, Mn), 2017-2028

Figure 28. India RNA Analysis Transcriptomics Revenue, (US$, Mn), 2017-2028

Figure 29. By Country - South America RNA Analysis Transcriptomics Revenue Market Share, 2017-2028

Figure 30. Brazil RNA Analysis Transcriptomics Revenue, (US$, Mn), 2017-2028

Figure 31. Argentina RNA Analysis Transcriptomics Revenue, (US$, Mn), 2017-2028

Figure 32. By Country - Middle East & Africa RNA Analysis Transcriptomics Revenue Market Share, 2017-2028

Figure 33. Turkey RNA Analysis Transcriptomics Revenue, (US$, Mn), 2017-2028

Figure 34. Israel RNA Analysis Transcriptomics Revenue, (US$, Mn), 2017-2028

Figure 35. Saudi Arabia RNA Analysis Transcriptomics Revenue, (US$, Mn), 2017-2028

Figure 36. UAE RNA Analysis Transcriptomics Revenue, (US$, Mn), 2017-2028

Figure 37. Thermo Fisher Scientific RNA Analysis Transcriptomics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

Figure 38. Bio-Rad Laboratories RNA Analysis Transcriptomics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

Figure 39. Merck KGaA RNA Analysis Transcriptomics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

Figure 40. Agilent Technologies RNA Analysis Transcriptomics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

Figure 41. Illumina RNA Analysis Transcriptomics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

Figure 42. QIAGEN N.V. RNA Analysis Transcriptomics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

Figure 43. F. Hoffmann-La Roche RNA Analysis Transcriptomics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

Figure 44. Danaher Corporation RNA Analysis Transcriptomics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

Figure 45. Fluidigm Corporation RNA Analysis Transcriptomics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

Figure 46. Eurofins Scientific RNA Analysis Transcriptomics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

Figure 47. Sequentia Biotech RNA Analysis Transcriptomics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

Figure 48. Acobiom RNA Analysis Transcriptomics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

Figure 49. GenXPro RNA Analysis Transcriptomics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

Figure 50. CD Genomics RNA Analysis Transcriptomics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

Figure 51. Promega Corporation RNA Analysis Transcriptomics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

Figure 52. Lexogen RNA Analysis Transcriptomics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

Figure 53. Cenix BioScience RNA Analysis Transcriptomics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

Methodology/Research Approach

This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

Research Programs/Design

Historical Data (2015-2019)	Industry Trends Competitive Landscape By Company Expansion Mergers and Acquisitions Market Segment by Type by Application By Regions/ Geography	Value Status and Outlook Value for Major Players Market Share Growth Rate Present Situation Analysis Value Market Share Growth Rate Present Situation Analysis
Influencing Factors	Market Environment Government Policy Technological Changes Market Risks	Market Drivers Growing Demand of Downstream Reduction in Cost
Market Forecast (2021-2026)	Overall Size by Type by Application By Regions/Geography	Key Data (Value) Market Share Growth Rate CAGR (2021-2026)

Market Size Estimation

Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).

The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.

Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.

All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report

The following figure shows an illustrative representation of the overall market size estimation process used for this study.

Market Breakdown and Data Triangulation

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.

Data Source

Secondary Sources

Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.

Market Size	Segmental value Geographic Penetration Product Adoption Rate for Different market	Journals, Websites, and Press Releases Annual Reports and SEC Filings Company Websites and Press Releases Public and Paid Databases Market Intellix Data Repository
Market Position of Top Company	Product Financials Geographic value Mix Total Company value Business/Segmental value Mix
Qualitative Analysis	Influence Factors Market Potential Market Risks and Opportunities Industry Trends Geographical Features Government Policies	Company Websites and Press Releases Public and Paid Databases Annual Reports Industry Associations Market Intellix Data Repository

Primary Sources

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.

Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.

Key Executives Interviewed

Key Data Information from Primary Sources

Primary Sources	Parameters	Key Data
Market Segments(by Application, by Type)	Value by Type Status and Forecast Value by Application Value by Regions, Status and Forecast (2021-2026)	Value Market Share by Type Value Growth Rate by Type Value by Application Percentage and Growth Rate by Application Value Growth Rate and Market Share by Regions Market Size Status and Forecast (2021-2026)
Total Market	Overall Size, Status and Forecast	Market Size Status and Forecast (2021-2026)